Emerging Roles of NANOS RNA-Binding Proteins in Cancer

Erkut Ilaslan1, Marcin Piotr Sajek1,2,3, Jadwiga Jaruzelska1

  • 1Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.

Insights

Mammalian Nanos RNA-binding proteins are overexpressed in cancers, promoting tumor growth and metastasis. Understanding their role in carcinogenesis is crucial for cancer therapy development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Mammalian Nanos RNA-binding proteins (Nanos1, Nanos2, Nanos3) are essential for germline development.
  • Recent studies indicate Nanos protein overexpression in various human cancers.
  • This overexpression is linked to oncogenic properties like cancer growth, invasiveness, and metastasis.

Purpose of the Study:

  • To review recent findings on the role of mammalian Nanos proteins in cancer.
  • To explore mechanisms behind Nanos protein overexpression in cancer.
  • To analyze expression profiles of human NANOS genes and their regulators in cancer.

Main Methods:

  • Literature review of recent findings on Nanos proteins in cancer.
  • Analysis of publicly available RNA-Seq datasets for human cancer and normal tissues.
  • Examination of expression profiles for NANOS genes and oncogenic transcriptional regulators.

Main Results:

  • Nanos proteins play significant roles in promoting cancer progression.
  • Overexpression of Nanos proteins is a common event in various malignancies.
  • Expression patterns of NANOS genes and regulators vary across different cancer types.

Conclusions:

  • Nanos proteins are functionally significant across human cancers.
  • Further research is needed to fully elucidate the role of Nanos proteins in carcinogenesis.
  • Targeting Nanos proteins may offer potential therapeutic strategies for cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.5K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K